Since January 2024, only 0.2% of people trying to quit smoking have used it (the same proportion that used it in 2018, when ...

According to the European Union, in 2024, EU exports of medicinal and pharmaceutical products increased by 13.5% compared ...

Analysts expect Johnson & Johnson to report an earnings per share (EPS) of $2.67. Johnson & Johnson bulls will hope to hear ...

The deal between the United States and the European Union may have averted a transatlantic trade war, but worries persist in ...

The health sector is witnessing notable developments. Bristol Myers and Pfizer are offering Eliquis at a discounted rate.

Johnson & Johnson’s stock rose 2.4% in premarket trading, enough to pace the Dow Jones Industrial Average’s early gainers.

Johnson & Johnson shares jumped to their highest price in more than three months as the US-based healthcare group shrugged off the impact of tariffs and raised its earnings and sales guidance for 2025 ...

Merck has launched a sweeping cost-cutting effort designed to save $3 billion annually by the end of 2027, the company said ...

Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.

June was a slower month on the pharma agency side, but were several hires worth reporting, as well as a couple of interesting ...

The market value of the company surpassed the size of Denmark’s entire economy last year and, for a period, Novo Nordisk was ...